CBD (Cannabidiol) CBD (cannabidiol) is the second most well-known phyto-cannabinoid after THC and generally the second most prevalent phyto-cannabinoid in the cannabis flower. As it is not psychotropic, CBD is not subject to the Narcotics Act. A doctor’s prescription is required however due to its known pharmacological effects. CBD binds to many different receptors (‘dirty …
THC (Δ9-Tetrahydrocannabinol) The best-known cannabinoid Δ9-tetrahydrocannabinol (Δ9-THC) is responsible for the renowned ‘high’ and for most people enjoyable psychotropic effects of cannabis. Since March 2017, THC and THC-containing substances have been classified in Germany within Appendix III of the narcotics law as prescription drugs. This article reviews the therapeutic potential of THC. Chemical formula: C21H30O2 …
Many physicians and patients worry that medical cannabis may trigger drug-induced psychosis or schizophrenia. Cannabis-induced psychosis, which symptomatically is similar to psychotic episodes of paranoid schizophrenia, at least shows a more favorable prognosis compared to other drug-related psychoses (also alcohol). It is no news that regular use of cannabis correlates with schizophrenic diseases, especially when …
Therapeutic Potential The pharmacological effects of cannabis are clinically evident. However, due to sociopolitical research hindrances, cannabis is currently only approved for a few indications (nausea and vomiting during chemotherapy, lack of appetite and cachexia in HIV or cancer, neuropathic or chronic pain and spasticity in MS). Therefore, the off-label or no-label use of non-approved …
Risks & Contraindications According to the WHO cannabis is a “relatively safe drug“ that has never led to overdose-related deaths. Acute side effects primarily affect the mind and psychomotoric functions as well as the heart and circulatory system. These effects usually vanish after a short period of time. Due to its psychotropic effects cannabis medication …
Our Products HAPA Medical Holding is a certified producer and wholesaler of high-quality full spectrum extracts from medical cannabis flowers. Advertisement for prescription drugs is not permitted outside of professional circles. Please take a look at our certificates from the ICCI (International Cannabis and Cannabinoid Institute): TESTRESULTS CBD CERTIFICATE Physicians and pharmacists find further information …
Personality, life events, genetic predisposition, lifestyle, sex, age and social environment are only a few examples for individual factors that influence our health and potential disease progression. New discoveries in basic research addressing the molecular processes of life constantly expand the understanding of health and disease. However, it takes a long period of time until …
In the treatment of physical ailments not only the elimination of pathogens plays a role. There also exists a complex communication network between the immune system and the brain via which these two main supervisory faculties of an organism influence each other. One example for this is stress and the influence of the so called …
Most people in western industrialized countries fall ill with lifestyle diseases like cardiovascular and neurodegenerative disorders, cancer, obesity and dysregulated immune responses due to an unhealthy lifestyle with too much stress and too little exercise. For instance, the excessive consumption of animal fats leads to increasing levels of arachidonic acid that is the initial substrate …
Medical Cannabis Phytocannabinoids from medicinal hemp act on the endocannabinoid system of the human body, which is involved in the regulation of a diversity of physiological functions, while displaying a very favourable safety profile. Many patients use cannabis as a replacement for prescription drugs that have a more unfavourable safety profile. Medicinal cannabis follows strict …
HAPA Medical is an international company focused on the research, development and distribution of cannabinoid-containing drug formulations. We stand for a controlled cultivation of cannabis plants in the EU as well as for the own production of prescription medicines according to EU-GMP-guidelines.
